Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Non-classical karyotypic features in relapsed childhood B-cell precursor acute lymphoblastic leukemia
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 1192914
Author(s) Wehrli, Lea A; Braun, Julia; Buetti, Luisa Nobile; Hagleitner, Nicole; Hengartner, Heinz; Kühne, Thomas; Lüer, Sonja; Ozsahin, Hulya; Popovic, Maja Beck; Niggli, Felix K; Betts, David R; Bourquin, Jean-Pierre
Author(s) at UniBasel Kühne, Thomas
Year 2009
Title Non-classical karyotypic features in relapsed childhood B-cell precursor acute lymphoblastic leukemia
Journal Cancer genetics and cytogenetics
Volume 189
Number 1
Pages / Article-Number 29-36
Abstract Karyotype analysis of acute lymphoblastic leukemia (ALL) at diagnosis has provided valuable prognostic markers for treatment stratification. However, reports of cytogenetic studies of relapsed ALL samples are limited. We compared the karyotypes from 436 nonselected B-cell precursor ALL patients at initial diagnosis and of 76 patients at first relapse. We noticed a relative increase of karyotypes that did not fall into the classic ALL cytogenetic subgroups (high hyperdiploidy, t(12;21), t(9;22), 11q23, t(1;19), <45 chromosomes) in a group of 29 patients at relapse (38%) compared to 130 patients at presentation (30%). Non-classical cytogenetic aberrations in these 29 patients were mostly found on chromosomes 1, 2, 7, 9, 13, 14, and 17. We also describe six rare reciprocal translocations, three of which involved 14q32. The most frequent abnormalities were found in 9p (12/29 cases) and were associated with a marked decrease in the duration of the second remission, but not of the probability of 10-year event-free survival after relapse treatment. From 29 patients with non-classical cytogenetic aberrations, only 8 (28%) had been stratified to a high risk-arm on the first treatment protocol, suggesting that this subgroup might benefit from the identification of new prognostic markers in future studies.
Publisher Elsevier
ISSN/ISBN 0165-4608
edoc-URL http://edoc.unibas.ch/dok/A6003162
Full Text on edoc No
Digital Object Identifier DOI 10.1016/j.cancergencyto.2008.10.002
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/19167609
ISI-Number WOS:000263213000005
Document type (ISI) Article
 
   

MCSS v5.8 PRO. 0.333 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
20/04/2024